{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:10:13Z","timestamp":1756289413494,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,10,12]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>A 23-year-old woman was referred to the allergy and immunology clinic for recurrent abdominal, cutaneous and joint swelling and pain with a history of mucosal infections since childhood. Her history and clinical findings were suggestive of two rare and complex disorders, hereditary angioedema (HAE) and Ehlers-Danlos syndrome (EDS). Her recurrent episodes of abdominal and joint pain were initially misattributed to more common diagnoses such as esophagitis, depression and chronic pain syndrome. However, the coexistence of HAE and EDS likely contributed to a delay in diagnoses as the combination of these two rare but overlapping disorders is less understood by physicians. She had persistently low levels of C4 and C1-esterase inhibitor (C1-INH) with low to low-normal C1-esterase function, normal C1Q and no C1Q antibodies. In the setting of recurrent abdominal pain with cutaneous swelling, this supported the diagnosis of HAE type I. The increase in joint extensibility with recurrent shoulder subluxations since childhood was a manifestation of EDS. Although no known genetic mutations were identified for EDS, her diagnosis was confirmed by a geneticist based on her clinical phenotype. Before the diagnosis of HAE and EDS, our patient had at least 100 visits\/year to the emergency department\/hospitalisations for these recurrent symptoms. After starting on C1-INH replacement therapy, the frequency has decreased 10-fold. She also noted a 70% improvement in her quality of life. Familiarity with these rare disorders will assist healthcare providers in recognising HAE and EDS and include them as part of their differential diagnoses. Early diagnosis is important for a patient\u2019s well-being as both these chronic disorders have been associated with poor quality of life. Additionally, proper diagnoses will reduce healthcare costs by preventing unnecessary procedures due to misdiagnoses. Proper treatment will help to decrease hospitalisations and avoidance of life-threatening consequences (such as asphyxiation from fatal laryngeal attacks of HAE and rupture of aneurysms in EDS).<\/jats:p>","DOI":"10.1136\/bcr-2019-231484","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T05:14:30Z","timestamp":1574918070000},"page":"e231484","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent swelling and pain in the abdomen and joints in a patient with hereditary angioedema and Ehlers-Danlos syndrome"],"prefix":"10.1136","volume":"12","author":[{"given":"My-Trang Thi","family":"Dang","sequence":"first","affiliation":[{"name":"College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA"},{"name":"Internal Medicine, Authority Health, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Ambort","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA"},{"name":"Internal Medicine, Authority Health, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Arrey-Mensah","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA"},{"name":"Internal Medicine, Authority Health, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"2025082702534813000_12.11.e231484.1","unstructured":"Kerrigan MJ , Naik P . C1 Esterase Inhibitor Deficiency. [Updated 2019 Feb 5]. In: StatPearls [Internet]. Treasure Island (FL). StatPearls Publishing, 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538166\/"},{"key":"2025082702534813000_12.11.e231484.2","unstructured":"Syndrome E-D , Reference GH . Us national library of medicine., 2017. Available: https:\/\/ghr.nlm.nih.gov\/condition\/ehlers-danlos-syndrome [Accessed Last accessed March 22, 2019]."},{"key":"2025082702534813000_12.11.e231484.3","doi-asserted-by":"crossref","unstructured":"Rodgers KR , Gui J , Dinulos MBP , et al . Ehlers-Danlos syndrome hypermobility type is associated with rheumatic diseases. Sci Rep 2018;7.","DOI":"10.1038\/srep39636"},{"key":"2025082702534813000_12.11.e231484.4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/gim.2017.138","article-title":"Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review","volume":"20","author":"D'hondt","year":"2018","journal-title":"Genet Med"},{"key":"2025082702534813000_12.11.e231484.5","doi-asserted-by":"publisher","DOI":"10.1177\/1941738112452385"},{"key":"2025082702534813000_12.11.e231484.6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/000313481307900622","article-title":"Surgical failures: is it the surgeon or the patient? the all too often missed diagnosis of Ehlers-Danlos syndrome","volume":"79","author":"Fogel","year":"2013","journal-title":"Am Surg"},{"key":"2025082702534813000_12.11.e231484.7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.amjms.2018.03.001","article-title":"Spectrum of gastrointestinal manifestations in joint hypermobility syndromes","volume":"355","author":"Botrus","year":"2018","journal-title":"Am J Med Sci"},{"key":"2025082702534813000_12.11.e231484.8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.iac.2018.04.004","article-title":"Association of postural tachycardia syndrome and Ehlers-Danlos syndrome with mast cell activation disorders","volume":"38","author":"Bonamichi-Santos","year":"2018","journal-title":"Immunol Allergy Clin N Am"},{"key":"2025082702534813000_12.11.e231484.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286418793766","article-title":"Application of immunotherapy for neurological manifestations in hypermobile Ehlers\u2013Danlos syndrome","volume":"11","author":"Araki","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"2025082702534813000_12.11.e231484.10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ajmg.c.31555","article-title":"Mast cell disorders in Ehlers-Danlos syndrome","volume":"175","author":"Seneviratne","year":"2017","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"2025082702534813000_12.11.e231484.11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.anai.2016.08.014","article-title":"Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting","volume":"117","author":"Zanichelli","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025082702534813000_12.11.e231484.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.05.055"},{"key":"2025082702534813000_12.11.e231484.13","doi-asserted-by":"publisher","DOI":"10.1159\/000328760"},{"key":"2025082702534813000_12.11.e231484.14","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.13384","article-title":"The International WAO\/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy"},{"key":"2025082702534813000_12.11.e231484.15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.anai.2018.07.025","article-title":"Long-Term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency","volume":"121","author":"Craig","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025082702534813000_12.11.e231484.16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaip.2013.07.002","article-title":"Us hereditary angioedema association medical Advisory board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency","volume":"1","author":"Zuraw","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025082702534813000_12.11.e231484.17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000486312","article-title":"Hereditary and acquired angioedema: heterogeneity of pathogenesis and clinical phenotypes","volume":"175","author":"Bova","year":"2018","journal-title":"Int Arch Allergy Immunol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-231484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:54:00Z","timestamp":1756288440000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-231484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,27]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bcr-2019-231484"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-231484","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}